Shoshan Y, Gomori M, Moss L, Bari S, Edery N, Den R
J Neurooncol. 2025; .
PMID: 39747715
DOI: 10.1007/s11060-024-04919-5.
Ma Y, Zhang W, Zhao Z, Lv J, Chen J, Yan X
Natl Sci Rev. 2024; 11(10):nwae350.
PMID: 39479528
PMC: 11523052.
DOI: 10.1093/nsr/nwae350.
Orobeti S, Sima L, Porosnicu I, Diplasu C, Giubega G, Cojocaru G
Sci Rep. 2024; 14(1):14866.
PMID: 38937505
PMC: 11211417.
DOI: 10.1038/s41598-024-65137-7.
Moghaddasi L, Bezak E
Cancers (Basel). 2023; 15(5).
PMID: 36900341
PMC: 10001318.
DOI: 10.3390/cancers15051550.
Kunikowska J, Morgenstern A, Pelka K, Bruchertseifer F, Krolicki L
Front Med (Lausanne). 2023; 9:1085245.
PMID: 36590948
PMC: 9800503.
DOI: 10.3389/fmed.2022.1085245.
Novel Carbon Ion and Proton Partial Irradiation of Recurrent Unresectable Bulky Tumors (Particle-PATHY): Early Indication of Effectiveness and Safety.
Tubin S, Fossati P, Carlino A, Martino G, Gora J, Stock M
Cancers (Basel). 2022; 14(9).
PMID: 35565361
PMC: 9101845.
DOI: 10.3390/cancers14092232.
Relative Efficacy of Ac-PSMA-617 and Lu-PSMA-617 in Prostate Cancer Based on Subcellular Dosimetry.
Lee H
Mol Imaging Radionucl Ther. 2022; 31(1):1-6.
PMID: 35114745
PMC: 8814544.
DOI: 10.4274/mirt.galenos.2021.63308.
Biologically Targeted Radiation Therapy: Incorporating Patient-Specific Hypoxia Data Derived from Quantitative Magnetic Resonance Imaging.
Her E, Haworth A, Sun Y, Williams S, Reynolds H, Kennedy A
Cancers (Basel). 2021; 13(19).
PMID: 34638382
PMC: 8507789.
DOI: 10.3390/cancers13194897.
Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate Cancer.
Birindelli G, Drobnjakovic M, Morath V, Steiger K, DAlessandria C, Gourni E
Cancers (Basel). 2021; 13(14).
PMID: 34298642
PMC: 8307065.
DOI: 10.3390/cancers13143429.
Alpha Radiation as a Way to Target Heterochromatic and Gamma Radiation-Exposed Breast Cancer Cells.
Svetlicic M, Bomhard A, Sterr C, Bruckner F, Plodowska M, Lisowska H
Cells. 2020; 9(5).
PMID: 32397212
PMC: 7291130.
DOI: 10.3390/cells9051165.
Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation.
Yard B, Gopal P, Bannik K, Siemeister G, Hagemann U, Abazeed M
Cancer Res. 2019; 79(21):5640-5651.
PMID: 31387923
PMC: 6825554.
DOI: 10.1158/0008-5472.CAN-19-0859.
A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
G Vogin , Wambersie A, Koto M, Ohno T, Uhl M, Fossati P
Radiat Oncol. 2019; 14(1):24.
PMID: 30709366
PMC: 6359776.
DOI: 10.1186/s13014-019-1224-1.
18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients.
Zhu W, Zhang Y, Kong L, Huang Y, Zheng J, Wang R
Onco Targets Ther. 2018; 11:4345-4353.
PMID: 30100740
PMC: 6065596.
DOI: 10.2147/OTT.S160456.
Fluorescent nuclear track detectors for alpha radiation microdosimetry.
Kouwenberg J, Wolterbeek H, Denkova A, Bos A
Radiat Oncol. 2018; 13(1):107.
PMID: 29880059
PMC: 5992759.
DOI: 10.1186/s13014-018-1034-x.
Targeted and Nontargeted α-Particle Therapies.
McDevitt M, Sgouros G, Sofou S
Annu Rev Biomed Eng. 2018; 20:73-93.
PMID: 29345977
PMC: 5988956.
DOI: 10.1146/annurev-bioeng-062117-120931.
Development of an integrated Monte Carlo model for glioblastoma multiforme treated with boron neutron capture therapy.
Moghaddasi L, Bezak E
Sci Rep. 2017; 7(1):7069.
PMID: 28765533
PMC: 5539248.
DOI: 10.1038/s41598-017-07302-9.
Mitochondrial stress controls the radiosensitivity of the oxygen effect: Implications for radiotherapy.
Richardson R, Harper M
Oncotarget. 2016; 7(16):21469-83.
PMID: 26894978
PMC: 5008299.
DOI: 10.18632/oncotarget.7412.
Linking the history of radiation biology to the hallmarks of cancer.
Boss M, Bristow R, Dewhirst M
Radiat Res. 2014; 181(6):561-77.
PMID: 24811865
PMC: 4072211.
DOI: 10.1667/RR13675.1.
Health risks of space exploration: targeted and nontargeted oxidative injury by high-charge and high-energy particles.
Li M, Gonon G, Buonanno M, Autsavapromporn N, de Toledo S, Pain D
Antioxid Redox Signal. 2013; 20(9):1501-23.
PMID: 24111926
PMC: 3936510.
DOI: 10.1089/ars.2013.5649.
Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation.
Wulbrand C, Seidl C, Gaertner F, Bruchertseifer F, Morgenstern A, Essler M
PLoS One. 2013; 8(5):e64730.
PMID: 23724085
PMC: 3665541.
DOI: 10.1371/journal.pone.0064730.
